Ault Glazer & Co., Inc. Makes Minority Investment in PerGenix, LLC.PerGenix Developing Products to Rollout in Early 2009 LOS ANGELES Los Angeles (lôs ăn`jələs, lŏs, ăn`jəlēz'), city (1990 pop. 3,485,398), seat of Los Angeles co., S Calif.; inc. 1850. -- Ault Glazer & Co., Inc. (Pink Sheets: AULT) ("AGC AGC Automatic Gain Control AGC Automotive Glass Cartridge (fuse) AGC Associated General Contractors AGC Associated General Contractors of America AGC Atypical Glandular Cells AGC Attorney-General's Chambers ") announced today Ault Glazer & Co., Inc. is investing in PerGenix, LLC (Logical Link Control) See "LANs" under data link protocol. LLC - Logical Link Control , a private company founded one year ago. The Founder and CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. , Mr. Robert Case, has an extensive background in the medical device and diagnostics field, and is bringing that experience to this new venture. The firm anticipates FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. clinical field testing of their product in the first quarter of 2009. The CEO of Ault Glazer & Co., Inc., Mr. Milton "Todd" Ault, III believes that this product holds huge promise. "We are incredibly impressed with Robert's 30 years of experience and knowledge in the diagnostics arena, and are excited to invest in a company that can provide lab quality testing in the convenience of a patient's home." "There must be clear actionable Giving sufficient legal grounds for a lawsuit; giving rise to a Cause of Action. An act, event, or occurrence is said to be actionable when there are legal grounds for basing a lawsuit on it. benefit from diagnostic testing Diagnostic testing Testing performed to determine if someone is affected with a particular disease. Mentioned in: Von Willebrand Disease for the home testing consumer and chronically ill patient," said Mr. Case. "This will require more understandable, accurate and robust home testing than current methods can provide. We believe this can be achieved through the wireless integration of the clinical lab into the testing regime to ensure the validity and interpretation of test results, followed by immediate and direct delivery of the results to both the consumer/patient and physician. Our unique offering seamlessly integrates these benefits into the consumer/patient's life without the current time and cost of the laboratory visit or physician appointment." Ault Glazer & Co., Inc. expects to make additional investments in the coming months in various industries. Terms of the transaction were undisclosed. More information on Ault Glazer & Co. can be found at www.aultglazer.com. About PerGenix LLC PerGenix develops and manufactures low cost, rapid, lab-quality diagnostics for the professional and consumer diagnostics market. The proprietary PerGenix Platform, usable at home or in clinics, will seamlessly and securely connect home testing consumers, retail clinics and chronically ill patients with licensed clinical labs, their physicians, peer reviewed Healthcare 2.0 databases and on-line electronic medical records. Diagnostic applications span healthcare screening, disease identification and disease monitoring. About Ault Glazer & Co., Inc. Ault Glazer & Co., Inc. (www.aultglazer.com), a holding company, which through its wholly-owned subsidiaries and minority interests, is engaged in a number of diverse business activities, which include: merchant banking; corporate lending; shareholder activism; Internet sales and marketing; real estate; healthcare; energy; consumer products & services; insurance and media. Forward-Looking Statement forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to relating to relate prep → concernant relating to relate prep → bezüglich +gen, mit Bezug auf +acc our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. The safe harbor Safe Harbor 1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated. 2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive. for forward-looking statements contained in the Securities Litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute. When a person begins a civil lawsuit, the person enters into a process called litigation. Reform Act of 1995 protects companies from liability for their forward-looking statements if they comply with the requirements of the Act. |
|
|||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion